Target intelligence / Profile preview

Stratum corneum barrier function improvement

Molecular classification
Other (biological function, not a molecule), Not applicable
01

Overview

The stratum corneum barrier function refers to the unique ability of the outermost layer of the epidermis to protect the body from environmental threats while preventing transepidermal water loss. This property is governed by a highly organized structure composed of dead keratinized cells (corneocytes) embedded within a lipid matrix rich in ceramides, free fatty acids, and cholesterol. The integrity of this barrier is critical for preventing infection, dehydration, and inflammation. Disruption due to genetic conditions (e.g., filaggrin mutations), disease (eczema, psoriasis), environmental exposures, or harsh treatments can compromise barrier function. Therapeutic interventions aim to restore this property by normalizing the lipid matrix, supporting corneocyte integrity, and reducing inflammation. "Stratum corneum barrier function improvement" describes a therapeutic outcome, not a specific molecular target, and is monitored using clinical tests like transepidermal water loss and hydration measurements.

Other names
Skin barrier enhancementEpidermal barrier restorationBarrier function repairStratum corneum integrity
02

Mechanism of action

Restoration of lipid matrix (replacement of ceramides, cholesterol, fatty acids); Reduction of inflammation; Enhancement of corneocyte cohesion; Support of natural moisturizing factor (NMF) content; Reduction of protease activity to prevent excessive desquamation.

03

Biological functions

Protection from pathogensPrevention of water loss (hydration)Chemical/mechanical barrierRegulation of immune signalingTransepidermal water loss reductionSupport of normal skin homeostasis
04

Disease associations

Inflammation (e.g., atopic dermatitis, eczema)Infection (loss of barrier increases infection risk)Other (dehydrated skin, barrier-defective genetic diseases like Netherton syndrome)
05

Safety considerations

Possible irritation or sensitization from topical agentsOverhydration (maceration)Allergic reactions to creams/ingredientsLong-term steroid use leading to skin thinning
06

Interacting drugs

Moisturizers (emollients, ceramide creams)

4 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Stratum corneum hydration (corneometry)Filaggrin expression/mutationCeramide and lipid profileSkin pH

Beyond the preview

Go deeper on Stratum corneum barrier function improvement.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stratum corneum barrier function improvement.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call